The Senate confirmed Robert Califf as the new FDA commissioner after months of delay, giving the cardiologist, clinical trial expert and established agency official a better platform to push his priorities, which include combination product and clinical data-collection reforms, while implementing projects already under way.
Robert Califf became the first cardiologist to serve as commissioner of FDA with an 89-4 vote of support in the Senate on Feb. 24.
He will replace acting commissioner Stephen Ostroff, who is expected to remain in the Office of the Commissioner during the...